Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.520 +0.990 (+15.16%)

Streaming Delayed Price Updated: 1:48 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival ↗

June 25, 2024

Via Benzinga

ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗

June 24, 2024

Via Benzinga

Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears ↗

June 24, 2024

A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees.

Via InvestorPlace

Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts ↗

June 24, 2024

Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.

Via InvestorPlace

Topics Workforce

3 Things You Need to Know if You Buy Ginkgo Bioworks Today ↗

May 25, 2024

It needs to work within the constraints imposed by these three issues.

Via The Motley Fool

How Is The Market Feeling About Ginkgo Bioworks Holdings? ↗

May 23, 2024

Via Benzinga

Is Ginkgo Bioworks Holdings Stock a Buy? ↗

May 18, 2024

Can this struggling stock turn things around?

Via The Motley Fool

5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains ↗

June 20, 2024

Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff.

Via InvestorPlace

7 Penny Stocks to Sell in June Before They Crash & Burn ↗

June 19, 2024

It's way past time to dump these seven struggling penny stocks before things go from bad to worse for investors.

Via InvestorPlace

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

June 11, 2024

These pharma and biotech players could become long-term winners.

Via The Motley Fool

3 Sorry Biotech Stocks to Sell in May While You Still Can ↗

May 31, 2024

Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.

Via InvestorPlace

Ginkgo Bioworks Stock: Bull vs. Bear ↗

May 31, 2024

This innovative biotechnology company hopes to turn things around.

Via The Motley Fool

Ginkgo Bioworks: Buy, Sell, or Hold? ↗

April 30, 2024

This company has a long way to go before investors will see rewards.

Via The Motley Fool

Should You Buy the Dip on Ginkgo Bioworks Stock? ↗

May 30, 2024

Its vision is ambitious, but can it actually be made to work?

Via The Motley Fool

2 Cathie Wood Biotech Stocks That Could Be Worth the Risk ↗

May 29, 2024

You don't need to buy her picks, but it's worth understanding them.

Via The Motley Fool

Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF ↗

May 28, 2024

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.

Via Benzinga

Topics ETFs

Down 72%. Is Ginkgo Bioworks a Buy on the Dip? ↗

May 25, 2024

The number of cell engineering partnerships Ginkgo Bioworks has is way up, but the same can't be said about its stock price.

Via The Motley Fool

Ginkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst ↗

May 20, 2024

Ginkgo Bioworks has become a penny stock -- and that's the least of its problems,

Via The Motley Fool

Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!' ↗

May 20, 2024

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500's recent record highs.

Via Benzinga

Topics ETFs Stocks

4 Small-Cap Value Stocks That Could Go Parabolic ↗

May 16, 2024

These four small-cap stocks scan as deeply undervalued right now.

Via The Motley Fool

What's the Difference Between Biotech Stocks and TechBio Stocks? ↗

May 15, 2024

A few enterprising businesses are marketing themselves differently.

Via The Motley Fool

TeraWulf Posts Weak Results, Joins StoneCo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

May 14, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 10, 2024

The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!

Via InvestorPlace

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

DNA Stock Earnings: Ginkgo Bioworks Holdings Meets EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

DNA stock results show that Ginkgo Bioworks Holdings met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Ginkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change' ↗

May 09, 2024

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47% and is a 52.91% decrease in sales year-over-year. The company said the...

Via Benzinga

3 Meme Stocks to Sell in May Before They Crash & Burn ↗

May 08, 2024

Traders have gravitated to meme stocks over the past year. But it's time to sell these three before the party ends.

Via InvestorPlace

Want $10,000? Invest $1,000 in These 3 Penny Stocks Now ↗

May 07, 2024

Let's dive into these three high-potential penny stocks to discover whether or not they offer genuine investment opportunities.

Via InvestorPlace

Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗

April 30, 2024

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Starting at /week.